Elixir Medical Reports European MDR CE Mark Approval & Launch of LithiX Hertz Contact IVL System
Shots:
- Elixir has reported European MDR CE Mark approval & commercial launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy (IVL) System in EU to improve calcium & percutaneous coronary intervention treatment
- LithiX is a transcatheter device that uses low-profile metal hemispheres on a semi-compliant balloon to apply HC Stress, creating deep & wide fractures while minimizing vessel injury
- Additionally, 6mos. data from PINNACLE I trial (n=60) in Belgium & the Netherlands showed that LithiX effectively treated complex calcified lesions. In OCT-imaged subset (n=32), stent expansion at MSA location was 101.38%, 93.95% & 102.81% in eccentric, concentric & nodular calcium lesions, respectively
Ref: Globenewswire | Image: Elixir
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
